Suzanne E. Sherman - Publications
Affiliations: | Natural Sciences | New College of Florida |
Year | Citation | Score | |||
---|---|---|---|---|---|
2008 | Scarpellini M, Gätjens J, Martin OJ, Kampf JW, Sherman SE, Pecoraro VL. Modeling the resting state of oxalate oxidase and oxalate decarboxylase enzymes. Inorganic Chemistry. 47: 3584-93. PMID 18399627 DOI: 10.1021/Ic701953G | 0.342 | |||
2000 | Odom D, Gramer CJ, Young VG, Hilderbrand SA, Sherman SE. Synthesis and characterization of magnesium and zinc complexes of 1,4,7-triazacyclononane-N-acetate. Potential models for the active site of RuBisCo Inorganica Chimica Acta. 297: 404-410. DOI: 10.1016/S0020-1693(99)00387-4 | 0.312 | |||
1990 | Coll M, Sherman SE, Gibson D, Lippard SJ, Wang AH. Molecular structure of the complex formed between the anticancer drug cisplatin and d(pGpG): C222(1) crystal form. Journal of Biomolecular Structure & Dynamics. 8: 315-30. PMID 2268406 DOI: 10.1080/07391102.1990.10507808 | 0.465 | |||
1988 | Sherman SE, Gibson D, Wang AHJ, Lippard SJ. Crystal and molecular structure of cis-[Pt(NH3)2[d(pGpG)]], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA Journal of the American Chemical Society. 110: 7368-7381. DOI: 10.1021/Ja00230A017 | 0.453 | |||
1988 | Sherman SE, Gibson D, Wang AHJ, Lippard SJ. Crystal and molecular structure of cis-[Pt(NH3)2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA Journal of the American Chemical Society. 110: 7368-7381. | 0.38 | |||
1987 | Sherman SE, Lippard SJ. Structural aspects of platinum anticancer drug interactions with DNA Chemical Reviews. 87: 1153-1181. DOI: 10.1021/Cr00081A013 | 0.392 | |||
1985 | Sherman SE, Gibson D, Wang AH, Lippard SJ. X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. Science (New York, N.Y.). 230: 412-7. PMID 4048939 DOI: 10.1126/Science.4048939 | 0.477 | |||
Show low-probability matches. |